- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DNA: 1,4-dihydroxy-2-naphthoic acid(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.2: 4 residues within 4Å:- Chain A: E.130, L.158
- Chain C: E.130, L.158
3 PLIP interactions:3 interactions with chain A- Water bridges: A:E.130, A:L.158, A:L.158
ACT.9: 2 residues within 4Å:- Chain B: W.324
- Chain C: R.179
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:R.179
- Salt bridges: C:R.179
- 2 x FMT: FORMIC ACID(Non-functional Binders)
FMT.3: 6 residues within 4Å:- Chain A: T.270, I.413, R.414, V.415, R.416
- Ligands: FMT.4
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:V.415, A:R.416
FMT.4: 5 residues within 4Å:- Chain A: P.272, R.273, T.410, I.413
- Ligands: FMT.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.273
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.5: 5 residues within 4Å:- Chain B: D.460, D.489, G.491, G.493
- Ligands: TOI.6
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.460, B:D.489, B:G.491, H2O.6
MG.12: 5 residues within 4Å:- Chain D: D.460, D.489, G.491, G.493
- Ligands: TOI.11
4 PLIP interactions:3 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.460, D:D.489, D:G.491, H2O.14
- 2 x TOI: (1~{R},2~{S},5~{S},6~{S})-2-[(1~{S})-1-[3-[(4-azanylidene-2-methyl-1~{H}-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl (phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-1,4-bis(oxidanyl)-4-oxidanylidene-butyl]-6-oxidanyl-5-(3-oxid anyl-3-oxidanylidene-prop-1-en-2-yl)oxy-cyclohex-3-ene-1-carboxylic acid(Non-covalent)
TOI.6: 35 residues within 4Å:- Chain A: P.47, G.48, S.49, R.50, E.75, T.98, T.101, A.102, R.127, N.137, Q.138
- Chain B: R.302, A.396, S.397, N.398, P.399, R.401, R.419, A.422, G.423, I.424, D.425, G.459, D.460, L.461, T.462, H.465, D.489, G.491, G.492, G.493, I.494, F.495, L.498
- Ligands: MG.5
41 PLIP interactions:24 interactions with chain B, 17 interactions with chain A- Hydrophobic interactions: B:A.422, B:I.424, B:I.424, B:L.461, B:I.494, B:F.495, B:F.495, B:L.498, A:P.47, A:T.98
- Hydrogen bonds: B:S.397, B:S.397, B:N.398, B:N.398, B:I.424, B:D.460, B:L.461, B:T.462, B:G.493, B:I.494, A:S.49, A:R.50, A:E.75, A:T.98, A:R.127, A:R.127, A:N.137, A:Q.138, A:Q.138, A:Q.138
- Water bridges: B:R.302, B:T.462, A:S.49, A:S.49, A:R.50, A:A.102
- Salt bridges: B:R.302, B:R.401, B:R.419, A:R.127
- pi-Stacking: B:F.495
TOI.11: 35 residues within 4Å:- Chain C: P.47, G.48, S.49, R.50, E.75, T.98, T.101, A.102, R.127, N.137, Q.138
- Chain D: R.302, A.396, S.397, N.398, P.399, R.401, R.419, A.422, G.423, I.424, D.425, G.459, D.460, L.461, T.462, H.465, D.489, G.491, G.492, G.493, I.494, F.495, L.498
- Ligands: MG.12
42 PLIP interactions:16 interactions with chain C, 26 interactions with chain D- Hydrophobic interactions: C:P.47, C:T.98, D:I.424, D:I.424, D:D.425, D:I.494, D:F.495, D:F.495, D:L.498
- Hydrogen bonds: C:S.49, C:R.50, C:E.75, C:R.127, C:R.127, C:N.137, C:Q.138, C:Q.138, C:Q.138, D:S.397, D:S.397, D:S.397, D:N.398, D:N.398, D:I.424, D:G.459, D:D.460, D:L.461, D:T.462, D:T.462, D:G.493, D:I.494
- Water bridges: C:S.49, C:R.50, C:A.102, C:A.102, D:R.401, D:R.401, D:D.489
- Salt bridges: C:R.127, D:R.302, D:R.401, D:R.419
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bashiri, G. et al., Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogenMycobacterium tuberculosis. J.Biol.Chem. (2020)
- Release Date
- 2020-02-19
- Peptides
- 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DNA: 1,4-dihydroxy-2-naphthoic acid(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 2 x FMT: FORMIC ACID(Non-functional Binders)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x TOI: (1~{R},2~{S},5~{S},6~{S})-2-[(1~{S})-1-[3-[(4-azanylidene-2-methyl-1~{H}-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl (phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-1,4-bis(oxidanyl)-4-oxidanylidene-butyl]-6-oxidanyl-5-(3-oxid anyl-3-oxidanylidene-prop-1-en-2-yl)oxy-cyclohex-3-ene-1-carboxylic acid(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bashiri, G. et al., Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogenMycobacterium tuberculosis. J.Biol.Chem. (2020)
- Release Date
- 2020-02-19
- Peptides
- 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C